Effects of JL13, a pyridobenzoxazepine compound, in dopaminergic and glutamatergic models of antipsychotic activity.

Saved in:
Bibliographic Details
Title: Effects of JL13, a pyridobenzoxazepine compound, in dopaminergic and glutamatergic models of antipsychotic activity.
Authors: Andrade YCP; Department of Pharmacology, Institute of Biological Sciences., Ropke J; Department of Pharmacology, Institute of Biological Sciences., Viana TG; Department of Pharmacology, Institute of Biological Sciences., Fanelli C; Department of Pharmacology, Institute of Biological Sciences., Minaldi E; Department of Pharmacology, Institute of Biological Sciences., Batista LA; Department of Pharmacology, Graduate School in Neuroscience, Universidade Federal de Minas Gerais, Belo Horizonte., Issy AC; Departament of Morphology, Estomatology and Basic Pathology, Faculty of Odontology of Ribeirão Preto, Universidade de São Paulo Ribeirão Preto., Del Bel EA; Departament of Morphology, Estomatology and Basic Pathology, Faculty of Odontology of Ribeirão Preto, Universidade de São Paulo Ribeirão Preto., Rodrigues LCM; Department of Physiological Sciences, Health Science Center, Universidade Federal do Espírito Santo, Vitória, Brazil., Liégeois JF; Department of Pharmacy, Laboratory of Medicinal Chemistry, Faculty of Medicine and CIRM, University of Liège, Liège, Belgium., Moreira FA; Department of Pharmacology, Institute of Biological Sciences.
Source: Behavioural pharmacology [Behav Pharmacol] 2021 Feb 01; Vol. 32 (1), pp. 2-8.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lippincott Williams and Wilkins Country of Publication: England NLM ID: 9013016 Publication Model: Print Cited Medium: Internet ISSN: 1473-5849 (Electronic) Linking ISSN: 09558810 NLM ISO Abbreviation: Behav Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1473-5849
DOI:10.1097/FBP.0000000000000595